glimepiride has been researched along with Autoimmune Diseases in 2 studies
glimepiride: structure given in first source
Autoimmune Diseases: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Eighty rats were studied for all treatment periods with 40 receiving a daily oral gavage dosage of glimepiride and 40 receiving a daily oral gavage dosage of vehicle solution." | 1.29 | Glimepiride-induced prevention of diabetes and autoimmune events in the BB rat: revised. ( Chan, EK; Charles, MA; Cheta, DM; Kunakorn, T; Lim, J, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, HJ | 1 |
| Jeong, IK | 1 |
| Hur, KY | 1 |
| Kim, SK | 1 |
| Noh, JH | 1 |
| Chun, SW | 1 |
| Kang, ES | 1 |
| Rhee, EJ | 1 |
| Choi, SH | 1 |
| Cheta, DM | 1 |
| Lim, J | 1 |
| Chan, EK | 1 |
| Kunakorn, T | 1 |
| Charles, MA | 1 |
1 trial available for glimepiride and Autoimmune Diseases
| Article | Year |
|---|---|
Comparison of Efficacy of Glimepiride, Alogliptin, and Alogliptin-Pioglitazone as the Initial Periods of Therapy in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Multicenter, Randomized, Controlled Study.
Topics: Autoimmune Diseases; Blood Glucose; Blood Glucose Self-Monitoring; Cholesterol; Diabetes Mellitus, T | 2022 |
1 other study available for glimepiride and Autoimmune Diseases
| Article | Year |
|---|---|
Glimepiride-induced prevention of diabetes and autoimmune events in the BB rat: revised.
Topics: Animals; Autoimmune Diseases; Blood Glucose; Diabetes Mellitus, Type 1; Glycosuria; Hypoglycemic Age | 1995 |